Artificial Intelligence in Medical Imaging Market Overview
As per Econ Market Research analysis, the Global Artificial Intelligence in Medical Imaging Market was valued at approximately US$ 2570 Billion in 2026 and is predicted to reach US$ 22970 Billion by 2035, expanding at a CAGR of 27.57% over the forecast duration. The base year is 2025.
AI in medical imaging involves using machine learning algorithms and deep learning techniques to analyse and interpret complex medical images such as X-rays, MRIs, and CT scans. These AI systems can detect abnormalities, assist in diagnosing diseases, and predict treatment outcomes, offering significant potential to transform healthcare delivery.
In recent years, the market has grown significantly due to reasons such as the increased frequency of chronic diseases, an aging population, and a growing desire for early and accurate diagnostic tools. Furthermore, advances in processing power, the availability of big data in healthcare, and supportive government initiatives have all expedited the use of AI in medical imaging. Key competitors in the market are constantly innovating and developing strategic collaborations to improve their AI capabilities and grow their market position.
Artificial Intelligence in Medical Imaging Dynamics
The increased prevalence of chronic diseases such as cancer and cardiovascular problems necessitates the use of precise and fast diagnostic technologies. The global population is aging, which raises the demand for effective diagnostic services. AI technological improvements, such as increased machine learning algorithms and deep learning approaches, have considerably improved image analysis accuracy and efficiency, making AI a vital tool in medical diagnostics. Furthermore, growing investments in healthcare infrastructure and favourable government policies are driving market expansion.
Conversely, the market faces several challenges that may impede its progress. High implementation costs and the need for substantial investment in sophisticated technology can be a barrier for many healthcare providers. Data privacy and security concerns also pose significant hurdles, as the integration of AI requires handling large volumes of sensitive patient information. Moreover, the effectiveness of AI in medical imaging is heavily reliant on the availability of extensive and high-quality training data, which can be difficult to obtain.
Artificial Intelligence in Medical Imaging Drivers
Technological Advancements in AI
Artificial intelligence developments, particularly in machine learning and deep learning, have considerably improved the capabilities of AI systems in medical imaging. These technologies allow for more accurate and efficient processing of complicated medical pictures including X-rays, MRIs, and CT scans. Enhanced algorithms can detect minute irregularities and patterns that human eyes may overlook, resulting in earlier diagnosis and better patient outcomes.
Furthermore, the integration of AI with sophisticated imaging modalities enables faster image processing and interpretation, lowering radiologists', burden and enhancing overall productivity in healthcare settings. As AI technology advances, its use in medical imaging is likely to become more sophisticated and pervasive, resulting in market development.
Increasing Prevalence of Chronic Diseases
The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is a major driver for the AI in Medical Imaging market. Early and accurate diagnosis is crucial for effective treatment and management of these conditions. AI-powered imaging solutions offer significant improvements in diagnostic accuracy, enabling early detection and intervention. For instance, AI algorithms can assist in identifying cancerous lesions at an early stage, improving the chances of successful treatment and patient survival rates. The growing demand for precise diagnostic tools in managing chronic diseases underscores the importance of AI in medical imaging, thereby fuelling market expansion.
Artificial Intelligence in Medical Imaging Restraints:
High Implementation Costs
The expensive cost of implementing AI in medical imaging is a key impediment to its wider adoption. Creating and deploying AI technology necessitates significant investments in modern hardware, software, and qualified humans. Many healthcare facilities, particularly in developing countries, may struggle to cover these high expenditures. Furthermore, the integration of AI systems with current imaging infrastructure may involve additional costs, such as maintenance and updates. These budgetary constraints may limit the accessibility and scalability of AI-powered imaging solutions, impeding market growth.
Data Privacy and Security Concerns
The use of AI in medical imaging involves handling large volumes of sensitive patient data, raising concerns about data privacy and security. Ensuring the confidentiality and integrity of patient information is paramount, as any breach could have severe consequences. Regulatory frameworks such as GDPR in Europe and HIPAA in the United States impose stringent requirements on data protection, adding complexity to the deployment of AI systems. Healthcare providers must invest in robust cybersecurity measures to safeguard patient data, which can be resource-intensive. These privacy and security challenges may deter some institutions from adopting AI technologies, posing a restraint to market growth.
Artificial Intelligence in Medical Imaging Opportunities:
Integration with Telemedicine
The combination of AI in medical imaging and telemedicine represents a substantial opportunity for industry growth. Telemedicine has acquired significant popularity, particularly during the COVID-19 pandemic, because it allows for remote consultation and diagnosis. Artificial intelligence-powered imaging systems can improve telemedicine services by delivering accurate and rapid diagnostic help, especially in remote or underserved locations.
For example, AI systems may analyse medical pictures remotely and provide diagnostic insights to healthcare workers, allowing for better decision-making and patient care. This synergy between AI and telemedicine can increase access to high-quality diagnostic services, especially in locations with low medical resources, promoting the adoption of AI in medical imaging.
Segment Overview
By Technology
The AI in Medical Imaging market can be segmented by technology into deep learning, natural language processing (NLP), computer vision, and others. Deep learning, a subset of machine learning, uses neural networks with multiple layers to analyze complex medical images, enabling precise detection and diagnosis of diseases. NLP, on the other hand, allows for the interpretation and understanding of medical reports and clinical notes, enhancing data extraction and analysis.
Computer vision, another critical technology, focuses on enabling machines to interpret visual data, crucial for analyzing medical images. Other technologies in this segment include various advanced algorithms and hybrid models that integrate multiple AI techniques to improve diagnostic accuracy and efficiency. Each of these technologies contributes uniquely to the enhancement of medical imaging, offering improved accuracy, efficiency, and the potential for early diagnosis.
By Deployment Type
The deployment type segment of AI in Medical Imaging is categorized into on-premise and cloud-based solutions. On-premise deployment involves installing the AI systems within the healthcare facility',s infrastructure, offering enhanced control over data security and system customization. This type is preferred by large institutions with the necessary resources to maintain and upgrade their systems.
Cloud-based deployment, meanwhile, provides flexibility and scalability, enabling healthcare providers to access powerful AI tools without significant upfront investment. Cloud solutions are particularly beneficial for smaller clinics and institutions with limited IT infrastructure, as they allow for easy updates and lower maintenance costs. Both deployment types address different needs within the healthcare industry, providing tailored solutions to diverse organizational requirements.
By Application
The AI in Medical Imaging market is also divided into applications, including X-ray, CT, MRI, ultrasound, and molecular imaging. Each application uses AI to improve image analysis and diagnostic accuracy. Artificial intelligence (AI) helps detect fractures, cancers, and other irregularities in X-ray imaging. AI increases the identification of internal injuries and diseases in CT scans, allowing for faster and more accurate diagnoses.
MRI applications benefit from AI by improving picture reconstruction and interpretation, especially in complicated neurological and musculoskeletal diseases. Artificial intelligence is being utilized to improve the clarity and detail of ultrasound imaging, which is frequently employed in obstetrics and cardiology. Molecular imaging, which includes PET and SPECT scans, uses AI to better understand cellular and molecular processes, which is critical for oncology and neurology.
By Offering
The AI in Medical Imaging market by offering is divided into hardware, software, and services. Hardware offerings include advanced imaging machines integrated with AI capabilities, such as AI-enhanced MRI or CT scanners. Software solutions include AI algorithms and platforms designed to analyze medical images, improve diagnostic accuracy, and streamline workflow.
These software solutions often include machine learning models and Data Analytics tools. Services in this segment cover a range of Professional Services such as system integration, training, maintenance, and consulting. These services ensure that healthcare providers can effectively implement and utilize AI technologies, maintaining system efficiency and maximizing the benefits of AI in medical imaging.
By Clinical Applications
AI in Medical Imaging has numerous clinical applications, including breast, cardiovascular, liver, lung, neurology, prostate, colon, and musculoskeletal. Each therapeutic field benefits from AI',s capacity to perform extensive image analysis and early diagnosis. For example, AI can improve mammography for breast cancer screening, detect cardiovascular irregularities in heart scans, and aid in the identification of liver illnesses using advanced imaging techniques.
AI helps neurologists diagnose neurological problems by enhancing brain imaging. AI',s precise picture interpretation improves detection of prostate and colon cancers. Artificial intelligence can help diagnose fractures and joint problems in musculoskeletal applications. These clinical applications highlight the broad impact of AI on numerous medical domains, increasing diagnostic capabilities and patient care.
By End-User
End-users of AI in Medical Imaging include hospitals, clinics, research laboratories, and others. Hospitals, being major healthcare providers, extensively use AI to enhance diagnostic accuracy, improve patient outcomes, and streamline operations. Clinics, often with limited resources, benefit from AI through improved diagnostic capabilities and efficiency, enabling them to provide higher quality care.
Research laboratories utilize AI in medical imaging for advanced research, developing new diagnostic tools and treatment methods. Other end-users include specialized diagnostic centers and academic institutions, which use AI to advance medical research and education. Each end-user segment highlights the versatility and wide applicability of AI in enhancing medical imaging across different healthcare settings.
Artificial Intelligence in Medical Imaging Overview by Region
North America leads the market, driven by robust healthcare systems, substantial investment in healthcare technology, and strong support from regulatory bodies like the FDA. The presence of major AI and healthcare companies, along with extensive research and development activities, further propels market growth in this region. The United States, in particular, shows significant advancements in AI-driven medical imaging, with numerous hospitals and research institutions integrating AI to enhance diagnostic accuracy and patient care.
In Europe, the market is also experiencing notable growth, supported by favourable government initiatives and funding programs aimed at improving healthcare services. Countries like Germany, the United Kingdom, and France are at the forefront, adopting AI technologies in medical imaging to address the rising burden of chronic diseases and improve diagnostic efficiency. The European Union',s regulatory framework ensures the safe and effective deployment of AI in healthcare, fostering innovation and adoption.
The Asia-Pacific area is emerging as a profitable market for AI in medical imaging, owing to rising healthcare spending, increased awareness of early disease detection, and rapid advances in AI technology. Countries such as China, Japan, and India are spending extensively in healthcare infrastructure and AI research, with the goal of improving diagnostic skills and managing the expanding patient population. The region',s vast population base and the rising frequency of chronic diseases provide enormous prospects for market expansion.
Artificial Intelligence in Medical Imaging Market Competitive Landscape
Major companies such as IBM Watson Health, Siemens Healthineers, Philips Healthcare, GE Healthcare, and NVIDIA are at the forefront, leveraging their extensive experience in healthcare technology and AI to develop advanced imaging solutions. These companies are continuously investing in research and development to enhance the capabilities of their AI-driven imaging tools, aiming to provide more accurate, efficient, and early diagnostic solutions.
Start-ups and smaller tech firms also play a crucial role in the competitive landscape, often driving innovation with their agility and specialized focus on AI technologies. Companies like Aidoc, Zebra Medical Vision, and Arterys are making significant strides by offering cutting-edge AI solutions that integrate seamlessly with existing imaging systems, thus gaining rapid adoption in the market. These firms often collaborate with larger healthcare providers and technology companies to scale their innovations and expand their market presence.
Strategic alliances and collaborations are prevalent in this sector, as companies seek to use their capabilities to produce comprehensive AI solutions. Collaborations between AI corporations and healthcare practitioners, for example, contribute to the real-world evaluation and refining of AI algorithms, ensuring that they effectively satisfy clinical needs. Furthermore, mergers and acquisitions are common, with larger corporations purchasing innovative start-ups to strengthen their AI skills and broaden their product offerings. Furthermore, regional enterprises are making an impact, particularly in Asia-Pacific, where local players are building AI solutions targeted to the region',s healthcare systems. The competitive landscape is dynamic and continuously expanding, with constant developments in AI technology and increasing investments propelling the market forward.
Artificial Intelligence in Medical Imaging Key Players:
OrCam
BenevolentAI
BioXcel Therapeutics Inc
Aitia
Qventus
K Health
Prognos Health
Viz.ai, Inc
mPulse Mobile
Suki AI, Inc
ZealthLife technologies Pte. Ltd
Owkin Inc.
Siemens Healthineers AG
EchoNous, Inc
Enlitic, Inc.
Artificial Intelligence in Medical Imaging Recent Developments
April 2024, Bayer has joined forces with Google Cloud to accelerate the creation of AI-driven solutions for radiologists. This collaboration aims to support healthcare professionals and improve patient care by leveraging Google Cloud',s advanced technology, including its generative AI tools. Together, they will tackle the challenges of developing scalable and compliant AI medical imaging software products, while ensuring robust data security measures are in place.
March 2024, GE HealthCare utilized NVIDIA technology to create their latest research model, SonoSAMTrack1. This innovative model integrates a foundational promptable model, SonoSAM1, to accurately segment objects within ultrasound images. SonoSAMTrack prioritizes the segmentation of anatomical structures, lesions, and other critical areas in ultrasound imagery. Additionally, SonoSAMLite offers a simplified iteration of SonoSAMTrack.
Artificial Intelligence in Medical Imaging Report Segmentation
Artificial Intelligence in Medical Imaging Market Segmentation
| Segment Category | Segment Values |
|---|---|
| Modality |
|
| Application |
|
Key Players
- Butterfly Network
- Viz.ai
- Aidoc
- Arterys
- Zebra Medical Vision (Nanox)
- Riverain
- Lunit
Table of Contents
1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET–REPORT OVERVIEW
- 1.1. SCOPE OF THE REPORT
- 1.2. MARKET SEGMENT ANALYSIS
- 1.3. REGULATORY SCENARIO BY REGION/COUNTRY
- 1.4. MARKET INVESTMENT SCENARIO STRATEGIC
- 1.5. MARKET ANALYSIS BY BY MODALITY (USD MILLION)
- 1.5.1 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY BY MODALITY (2026-2035)
- 1.5.2 CT SCAN
- 1.5.3 MRI
- 1.5.4 X-RAY
- 1.5.5 ULTRASOUND SCANNERS
- 1.6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY BY MODALITY IN 2026 & 2035
- 1.7. MARKET ANALYSIS BY BY APPLICATION (USD MILLION)
- 1.7.1 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY BY APPLICATION (2026-2035)
- 1.7.2 NEUROLOGY
- 1.7.3 ONCOLOGY
- 1.7.4 CARDIOVASCULAR
- 1.7.5 DIGITAL PATHOLOGY
- 1.8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY BY APPLICATION IN 2026 & 2035
2. DRIVER RESTRAINT CHALLENGE AND OPPORTUNITIES OF ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET
- 2.1. DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
- 2.1.1 MARKET DRIVER ANALYSIS
- 2.1.2 MARKET RESTRAINT ANALYSIS
- 2.1.3 MARKET OPPORTUNITY
- 2.2. MARKET CHALLENGES
3. GLOBAL GROWTH TRENDS
- 3.1. INDUSTRY TRENDS
- 3.1.1 SWOT ANALYSIS
- 3.1.1.1 Strengths
- 3.1.1.2 Weaknesses
- 3.1.1.3 Opportunities
- 3.1.1.4 Threats
- 3.1.2 PESTEL ANALYSIS
- 3.1.2.1 Political Landscape
- 3.1.2.2 Economic Landscape
- 3.1.2.3 Social Landscape
- 3.1.2.4 Technological Landscape
- 3.1.2.5 Environmental Landscape
- 3.1.2.6 Legal Landscape
- 3.1.3 PORTER'S FIVE FORCES ANALYSIS
- 3.1.3.1 Bargaining Power of Suppliers
- 3.1.3.2 Bargaining Power of Buyers
- 3.1.3.3 Threat of Substitute
- 3.1.3.4 Threat of New Entrant
- 3.1.3.5 Competitive Rivalry
- 3.1.1 SWOT ANALYSIS
- 3.2. POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4. POST COVID ANALYSIS
- 4.1. COVID V ANALYSIS
- 4.2. COVID U ANALYSIS
- 4.3. COVID L ANALYSIS
- 4.4. COVID W ANALYSIS
5. COMPANIES ANALYSIS
- 5.1. PLAYERS COVERED: RANKING BY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET REVENUE
- 5.2. TOP COMPANIES MARKET SHARE (%)
6. EXECUTIVE SUMMARY
7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET FORECAST, 2022-2035, (USD MILLION)
- 7.1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET REVENUE AND MARKET SHARE BY REGIONS
- 7.2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY REGION (2022-2029)
- 7.3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY REGION (2030-2035)
- 7.3.1.1 North America
- 7.3.1.2 Europe
- 7.3.1.3 Asia Pacific
- 7.3.1.4 Latin America
- 7.3.1.5 Middle East & Africa
8. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 8.1. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 8.2. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 8.3. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 8.3.1.1 United States
- 8.3.1.2 Canada
- 8.3.1.3 Mexico
9. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 9.1. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 9.2. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 9.3. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 9.3.1.1 United Kingdom
- 9.3.1.2 Germany
- 9.3.1.3 France
- 9.3.1.4 Spain
- 9.3.1.5 Italy
- 9.3.1.6 Rest of Europe
10. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 10.1. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 10.2. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 10.3. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 10.3.1.1 China
- 10.3.1.2 India
- 10.3.1.3 Japan
- 10.3.1.4 Australia
- 10.3.1.5 South Korea
- 10.3.1.6 Rest of Asia Pacific
11. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 11.1. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 11.2. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 11.3. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 11.3.1.1 Saudi Arabia
- 11.3.1.2 South Africa
- 11.3.1.3 Rest of MEA
12. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 12.1. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 12.2. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 12.3. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 12.3.1.1 Brazil
- 12.3.1.2 Argentina
- 12.3.1.3 Rest of Latin America
13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SEGMENT BY BY MODALITY, (USD MILLION)
- 13.1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2022-2029)
- 13.2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2030-2035)
- 13.3. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2022-2029)
- 13.4. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2030-2035)
- 13.5. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2022-2029)
- 13.6. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2030-2035)
- 13.7. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2022-2029)
- 13.8. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2030-2035)
- 13.9. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2022-2029)
- 13.10. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2030-2035)
- 13.11. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2022-2029)
- 13.12. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY MODALITY (2030-2035)
13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SEGMENT BY BY APPLICATION, (USD MILLION)
- 13.13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2022-2029)
- 13.14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2030-2035)
- 13.15. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2022-2029)
- 13.16. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2030-2035)
- 13.17. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2022-2029)
- 13.18. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2030-2035)
- 13.19. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2022-2029)
- 13.20. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2030-2035)
- 13.21. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2022-2029)
- 13.22. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2030-2035)
- 13.23. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2022-2029)
- 13.24. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET AND MARKET SHARE BY BY APPLICATION (2030-2035)
14. COMPANY PROFILES
- 14.1. BUTTERFLY NETWORK
- 14.1.1 COMPANY DETAIL
- 14.1.2 FINANCIALS (USD MILLIONS)
- 14.1.3 PRODUCT SUMMARY
- 14.1.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.2. VIZ.AI
- 14.2.1 COMPANY DETAIL
- 14.2.2 FINANCIALS (USD MILLIONS)
- 14.2.3 PRODUCT SUMMARY
- 14.2.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.3. AIDOC
- 14.3.1 COMPANY DETAIL
- 14.3.2 FINANCIALS (USD MILLIONS)
- 14.3.3 PRODUCT SUMMARY
- 14.3.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.4. ARTERYS
- 14.4.1 COMPANY DETAIL
- 14.4.2 FINANCIALS (USD MILLIONS)
- 14.4.3 PRODUCT SUMMARY
- 14.4.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.5. ZEBRA MEDICAL VISION (NANOX)
- 14.5.1 COMPANY DETAIL
- 14.5.2 FINANCIALS (USD MILLIONS)
- 14.5.3 PRODUCT SUMMARY
- 14.5.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.6. RIVERAIN
- 14.6.1 COMPANY DETAIL
- 14.6.2 FINANCIALS (USD MILLIONS)
- 14.6.3 PRODUCT SUMMARY
- 14.6.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.7. LUNIT
- 14.7.1 COMPANY DETAIL
- 14.7.2 FINANCIALS (USD MILLIONS)
- 14.7.3 PRODUCT SUMMARY
- 14.7.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
15. CONCLUSION
16. REFERENCE LINK
17. APPENDIX
- 17.1. METHODOLOGY
- 17.2. RESEARCH DATA SOURCE
- 17.2.1 SECONDARY DATA
- 17.2.2 KEY DATA FROM SECONDARY
- 17.2.3 PRIMARY DATA
- 17.2.4 KEY DATA FROM PRIMARY
- 17.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
- 17.2.6 MARKET ESTIMATION
- 17.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
- 17.2.8 LEGAL DISCLAIMER
18. RESEARCH SCOPE
LIST OF TABLES
- TABLE 1. MARKET SEGMENT
- TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET GROWTH RATE BY BY MODALITY (2026-2035)
- TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET GROWTH RATE BY BY APPLICATION (2026-2035)
- TABLE 4. COMPANY'S RANK BY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET REVENUE
- TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET — MARKET SNAPSHOT & KEY BUYING CRITERIA, 2026–2035
- TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY REGION, USD MILLION (2022-2029)
- TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY REGION, (2022-2029)
- TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY REGION, USD MILLION (2030-2035)
- TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY REGION, (2030-2035)
- TABLE 12. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 13. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 14. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 15. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 16. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 17. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 18. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 19. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 20. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 21. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 22. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2022-2029)
- TABLE 23. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 24. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2030-2035)
- TABLE 25. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 26. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 27. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 28. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 29. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 30. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 31. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 32. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2022-2029)
- TABLE 33. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 34. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2030-2035)
- TABLE 35. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 36. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 37. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 38. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 39. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 40. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 41. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 42. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 43. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 44. ITALY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 45. ITALY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 46. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 47. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 48. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2022-2029)
- TABLE 49. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 50. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2030-2035)
- TABLE 51. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 52. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 53. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 54. INDIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 55. INDIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 56. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 57. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 58. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 59. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 60. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 61. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 62. REST OF ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 63. REST OF ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 64. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2022-2029)
- TABLE 65. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 66. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2030-2035)
- TABLE 67. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 68. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 69. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 70. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 71. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 72. REST OF MEA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 73. REST OF MEA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 74. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2022-2029)
- TABLE 75. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 76. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY COUNTRY, (2030-2035)
- TABLE 77. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 78. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 79. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 80. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 81. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 82. REST OF LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2022-2029)
- TABLE 83. REST OF LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (USD MILLION) (2030-2035)
- TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2022-2029)
- TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2030-2035)
- TABLE 86. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2022-2029)
- TABLE 87. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2030-2035)
- TABLE 88. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2022-2029)
- TABLE 89. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2030-2035)
- TABLE 90. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2022-2029)
- TABLE 91. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2030-2035)
- TABLE 92. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2022-2029)
- TABLE 93. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2030-2035)
- TABLE 94. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2022-2029)
- TABLE 95. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY MODALITY, USD MILLION (2030-2035)
- TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2022-2029)
- TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2030-2035)
- TABLE 98. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2022-2029)
- TABLE 99. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2030-2035)
- TABLE 100. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2022-2029)
- TABLE 101. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2030-2035)
- TABLE 102. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2022-2029)
- TABLE 103. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2030-2035)
- TABLE 104. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2022-2029)
- TABLE 105. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2030-2035)
- TABLE 106. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2022-2029)
- TABLE 107. SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET BY BY APPLICATION, USD MILLION (2030-2035)
LIST OF FIGURES
- FIGURE 1. MARKET OVERVIEW
- FIGURE 2. REGIONAL SHARE
- FIGURE 3. MARKET REVENUE (USD MILLION)
- FIGURE 4. DROC OF ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET ANALYSIS
- FIGURE 5. SWOT ANALYSIS
- FIGURE 6. PESTEL ANALYSIS
- FIGURE 7. PORTER'S FIVE FORCES ANALYSIS
- FIGURE 8. COVID V, U, W AND L ANALYSIS
- FIGURE 9. LEADING COMPANIES
- FIGURE 10. REGIONAL ANALYSIS
- FIGURE 11. COUNTRY ANALYSIS
- FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION), BY REGION
- FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2026), BY REGION
- FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION), BY REGION
- FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2035), BY REGION
- FIGURE 18. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 19. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 20. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 21. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 22. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 23. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 24. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 25. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 26. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 27. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 28. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 29. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2026), BY COUNTRY
- FIGURE 30. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 31. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2035), BY COUNTRY
- FIGURE 32. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 33. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 34. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 35. CANADA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 36. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 37. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 38. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 39. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2026), BY COUNTRY
- FIGURE 40. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 41. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2035), BY COUNTRY
- FIGURE 42. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 43. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 44. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 45. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 46. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 47. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 48. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 49. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 50. ITALY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 51. ITALY ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 52. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 53. REST OF EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 54. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 55. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2026), BY COUNTRY
- FIGURE 56. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 57. ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2035), BY COUNTRY
- FIGURE 58. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 59. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 60. INDIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 61. INDIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 62. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 63. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 64. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 65. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 66. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 67. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 68. REST OF ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 69. REST OF ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 70. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 71. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2026), BY COUNTRY
- FIGURE 72. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 73. MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2035), BY COUNTRY
- FIGURE 74. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 75. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 76. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 77. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 78. REST OF MEA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 79. REST OF MEA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 80. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 81. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2026), BY COUNTRY
- FIGURE 82. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 83. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, (2035), BY COUNTRY
- FIGURE 84. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 85. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 86. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 87. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
- FIGURE 88. REST OF LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2022-2029), (USD MILLION)
- FIGURE 89. REST OF LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (2030-2035), (USD MILLION)
Research Methodology
Our research methodology is carefully designed to deliver the clients with the most accurate, relevant, and actionable market insights to enable clear decision-making and leveraging of opportunities in the markets. We believe consistency, depth in analysis, and a tailored approach in each report are what help set us apart in the industry. The research methodology is based on an integrating research process consisting of in-depth data collection, a complex analysis, and a stringent validation system.
Data Collection
Data collection forms the basis of our study and gathers diverse authentic data to build the basis for deeper study in terms of market trends, competitive landscape, and growth prospects. Data collection takes place through two channels of main activities as follows:
Primary Data Collection
Primary data collection allows collecting real-time and firsthand information from market participants. This is an engagement process conducted by our team with other industry stakeholders, where a much deeper insight than any published data is pursued. This process includes:
- Direct Interviews – We interview the key decision-makers such as CEOs, product managers, innovation heads, and marketing directors to gather both qualitative and quantitative information. The questionnaire covers emerging trends, customer preferences, regulatory impact, and competitors’ strategies.
- Demand and Supply-Side Inputs – Interviews and surveys with supply and demand-side stakeholders provide a balanced view of prevailing market conditions, including feedback from manufacturers, distributors, suppliers, and end-users.
- Expert Opinions – Consultations with industry experts and domain specialists provide insights into future market direction, risks, and opportunities.
- Focus Groups and Online Surveys – Focus groups and surveys are used to understand consumer preferences and adoption probability of new products or services.
Primary research forms the core of our data validation process by offering direct insights into the market, addressing limitations in secondary data, and allowing for an adaptable research process.
Secondary Data Collection
Secondary research serves as a robust foundation for understanding market context, historical data, and larger trends. It involves systematic gathering of existing information from verified sources.
- Industry Reports and Publications – Market reports, white papers, and case studies from credible sources provide a broad view of the market landscape and key players.
- Government and Public Records – Data from government agencies and regulatory bodies helps analyze economic factors and policy impacts.
- News and Media Outlets – Monitoring news articles, press releases, and media reports keeps us updated on market developments and M&A activity.
- Proprietary and Paid Databases – Databases such as Bloomberg, Factiva, D&B Hoovers, and Thomson Reuters provide validated and cross-referenced data.
- Financial Reports and SEC Filings – Financial statements, annual reports, and investor presentations provide insights into revenue structures and profitability.
This combination of primary and secondary data sources enables us to provide a comprehensive view of the market, supported by authenticated information across multiple sources.
Data Analysis Techniques
With the data collected, we initiate a rigorous analysis phase. We analyze market dynamics, growth patterns, and future performance using analytical models and statistical tools.
Top-Down and Bottom-Up Market Sizing Approaches
- Top-Down Approach – Starts with global market size and distributes it across segments using macro-level trends and established proportions.
- Bottom-Up Approach – Aggregates company-level and country-level revenue data to build regional and global market estimates.
These two approaches are cross-validated to remove inconsistencies and ensure accurate market estimation.
Forecasting Models and Market Dynamics Analysis
- Time-Series Analysis – Models historical trends, seasonality, and demand cycles.
- Econometric and Judgmental Forecasting – Combines economic models with expert-driven adjustments.
- Delphi Method – Uses iterative expert input to generate balanced market forecasts.
Data Triangulation and Validation
- Multi-source cross-verification of all data points
- Use of quantitative and qualitative validation techniques
- Sample validation through expert and stakeholder feedback
Market Analysis and Sizing Estimation
- Detailed segmentation analysis
- Competitive landscape evaluation
- Revenue modeling using TAM, SAM, and SOM frameworks
Quality Assurance and Final Review
- Data accuracy and consistency checks
- Content, language, and structure review
- Client-specific customization and refinement
Continuous Improvement in Methodology
We continuously refine our research methodologies based on evolving market conditions, client feedback, and technological advancements. This ensures our research remains accurate, relevant, and aligned with industry standards.
Artificial Intelligence in Medical Imaging Market Report Scope & Segmentation
| Attributes | Details |
|---|---|
| Market Size (Current)Current market valuation | US$ 2570 Billion in 2026 |
| Market Size (Forecast)Projected market valuation | US$ 22970 Billion in 2035 |
| Growth RateCompound Annual Growth Rate | CAGR of 27.57% from 2026 to 2035 |
| Forecast PeriodAnalysis timeline | 2026 – 2035 |
| Base YearReference year for analysis | 2025 |
| Historical Data AvailablePast market data availability | Yes |
| Regional ScopeGeographical coverage | Global |
| Segments CoveredMarket segments analyzed | By Modality
By Application
|
Leading companies covered in this report
- Butterfly Network
- Viz.ai
- Aidoc
- Arterys
- Zebra Medical Vision (Nanox)
- Riverain
- Lunit
Frequently Asked Questions
Common questions about this report
The study period covers historical insights and forecast projections for the period 2026-2035.
The global Artificial Intelligence in Medical Imaging Market market is expected to grow at a CAGR of 27.57% during the forecast period 2026-2035.
The report offers comprehensive market segmentation analysis across key categories and sub-segments relevant to the industry, along with regional and competitive insights.
The market is projected to reach 22970 Billion by 2035.
Key players in the Artificial Intelligence in Medical Imaging Market include Butterfly Network, Viz.ai, Aidoc, Arterys, Zebra Medical Vision (Nanox), Riverain, and Lunit.
North America, Europe, and Asia Pacific are key regions covered in the report, including regional trends, market share, and growth opportunities.
Growing demand, technological advancements, changing consumer preferences, and increasing investments are some of the major factors supporting the growth of the Artificial Intelligence in Medical Imaging Market market.
Yes, the report includes company profiling, competitive landscape analysis, strategic developments, mergers & acquisitions, product launches, and market positioning of leading industry participants.
The report is prepared using a combination of primary research, secondary research, expert interviews, industry databases, company annual reports, and proprietary market analysis models.
Yes, report customization options are available based on specific business objectives, geographic focus, competitive benchmarking requirements, and additional market segmentation needs.
Yes, the report is available in both PDF and Excel formats. The Excel file includes all market data tables, forecasts, and segment-wise data for easy analysis.
Yes, you can request a free sample report which includes an overview, table of contents, and sample data pages to help you evaluate the report before making a purchase decision.
About the Author
Market research expert with years of industry experience

Dipali Bhingare serves as the Market Research Director at Econ Market Research. With a focus on translating complex global economic shifts into actionable business intelligence, she oversees the strategic direction of comprehensive market studies. Her work empowers organizations to navigate volatile industries through data-driven forecasting and deep-dive competitive analysis.










